Institutional investors purchased a net $178.4 thousand shares of SGEN during the quarter ended June 2017 and now own 99.50% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 1.3 Million shares of Seattle Genetics Inc
HENDERSON GLOBAL INVESTORS LTD. Bought 704.7 Thousand shares of Seattle Genetics Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 696.0 Thousand shares of Seattle Genetics Inc